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ABSTRACT
Objective: To evaluate the quality of life in children 
and adolescents with sickle cell disease attending a blood 
reference center, and to assess the quality of life of their 
relatives.
Methods: Cross-sectional study that included 100 patients 
with sickle cell disease, which were divided into three sub-
groups according to age: 5 to 7 (n=18), 8 to 12 (n=32), and 13 
to 18 years-old (n=50), and their parents. The Control Group 
included 50 healthy children and adolescents from a public 
local school, also divided into the same three age subgroups 
and their caregivers. The Pediatric Quality of life Inventory 
(PedsQL),  version 4.0, was applied in both groups. The generic 
questionnaire Medical Outcomes Study 36 - Item Short-Form 
Health Survey (SF-36) was applied to the relatives. The answers 
were linearly transformed into a score and compared by non-
parametric tests. 
Results: The PedsQL scores of patients were significantly 
lower than those obtained in the Control Group (p<0.0001) in 
all studied areas (physical, emotional, social skills, and school 
activities). Similarly, SF-36 scores applied to the patients’ par-
ents were lower than those obtained in the Control Group in 
all studied aspects (p<0.0001).
Conclusions: Sickle cell disease affects the quality of life 
of children, adolescents, and their families. Patients sense re-
strictions in the emotional, social, family and physical aspects, 
among others. 
Key-words: quality of life; anemia, sickle cell; children; 
adolescents.
RESUMO
Objetivo: Avaliar a qualidade de vida relacionada à saúde 
de crianças e adolescentes com doença falciforme assistidas em 
um hemocentro de referência e mensurar a qualidade de vida 
relacionada à saúde dos respectivos familiares. 
Métodos: Estudo transversal e seccional com 100 pacientes 
portadores de doença falciforme, divididos em três subgrupos 
conforme a faixa etária: de 5 a 7 (n=18), de 8 a 12 (n=32) e de 13 
a 18 anos (n=50) e com seus respectivos pais. O Grupo Controle 
foi composto por 50 crianças e adolescentes saudáveis de uma 
escola pública local, também divididos nos três subgrupos de 
idade e seus respectivos cuidadores. Foi aplicado o questionário 
genérico “Pediatric Quality of Life Inventory” (PedsQL), versão 4.0, 
em ambos os grupos. Aos familiares foi aplicado o questionário 
genérico Medical Outcomes Study 36 – Item Short-Form Health Survey 
(SF-36). As respostas obtidas foram linearmente transformadas em 
um escore e comparadas com o auxílio de testes não paramétricos. 
Resultados: Os escores dos pacientes no PedsQL foram 
inferiores àqueles do Grupo Controle (p<0,0001) nos aspectos 
estudados (capacidades física, emocional, social e atividade esco-
lar). Da mesma forma, os escores do SF-36 aplicados aos pais dos 
pacientes foram mais baixos que os de pais do Grupo Controle 
em todos os aspectos estudados (p<0,0001). 
Conclusões: A doença falciforme compromete a qualidade de 
vida das crianças, dos adolescentes e de suas respectivas famílias. 
Os pacientes percebem restrições nos aspectos emocional, social, 
familiar e físico, dentre outros.
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RESUMEN
Objetivo: Evaluar la calidad de vida relacionada a la salud 
en niños y adolescentes con enfermedad falciforme asistidas 
en un servicio de hemoterapia de referencia y medir la calidad 
de vida relacionada a la salud de los respectivos familiares. 
Métodos: Estudio transversal y seccional en 100 pacien-
tes portadores de enfermedad falciforme, divididos en tres 
subgrupos conforme a la franja de edad: de 5 a 7 (n=18), de 
8 a 12 (n=32) y de 13 a 18 (n=50) años con sus respectivos 
padres. El Grupo Control fue compuesto por 50 niños y 
adolescentes sanos de una escuela pública local, también 
divididos en los mismos tres subgrupos de edad y sus respec-
tivos cuidadores. Se aplicó el cuestionario genérico «Pediatric 
Quality of Life Inventory» (PedsQL), versión 4.0, a ambos 
grupos. A los familiares se aplicó el cuestionario genérico 
Medical Outcomes Study 36 – Item Short-Form Health 
Survey (SF-36). Las respuestas obtenidas fueron linealmente 
transformadas en un escore y comparadas con la ayuda de 
pruebas no paramétricas. 
Resultados: Los escores de los pacientes en el PedsQL 
fueron inferiores a aquellos del Grupo Control (p<0,0001) 
en los aspectos estudiados (capacidades física, emocional, 
social y actividad escolar). Del mismo modo, los escores del 
SF-36 aplicados a los padres de los pacientes fueron más bajos 
que los de padres del Grupo Control en todos los aspectos 
estudiados (p<0,0001). 
Conclusiones: La enfermedad falciforme compromete 
la calidad de vida de los niños, de los adolescentes y de sus 
respectivas familias. Los pacientes perciben restricciones en 
los aspectos emocional, social, familiar y físico, entre otros.
Palabras clave: calidad de vida; anemia falciforme; niños; 
adolescentes.
Introduction
Sickle cell disease (SCD) is a chronic hemolytic hereditary 
anemia resulting from a mutation in which valine substitutes 
for glutamic acid in codon 6 of the β-hemoglobin chain, 
which leads to the formation of hemoglobin S. This basic 
defect is the main cause of the various clinical signs and 
symptoms of this disease(1). SCD  is the result of a combina-
tion of hemoglobin S (HbS) with another abnormal hemo-
globin, such as hemoglobin C (HbC), beta-thalassemia and 
HbS, which characterize hemoglobinopathies HbSC, HbS 
beta-thalassemia and HbSS(2,3). Sickle cell anemia is the most 
severe form of sickle cell disease. In Brazil, it is classified 
as a public health problem because of its high prevalence(4). 
SCD has high morbidity and mortality. It is characterized 
by acute clinical symptoms, such as painful vasculo-occlusive 
episodes, splenic sequestration and acute thoracic syndrome, 
that make the patient seek the emergency services frequently, 
and also by chronic signs, as it affects organs and systems. 
Survival and quality of life improvement for these patients is 
based on general and preventive measures(5). Several changes 
affect the life of patients with SCD  which force them to face 
limitations, frustrations and losses and to adapt to a new 
life style. These changes are necessary because of the use 
of medications, hospitalizations and lost working capacity. 
Because of these events, there may also be a variable impact 
on their health-related quality of life (HRQL)(6-8).
HRQL is a construct made up of different elements: bio-
logical, social and relational, psychological and of functional 
autonomy. They come together for individuals to evaluate 
how much more or less quality their life has(9,10). In the last 
decades, several instruments have been designed to measure 
quality of life of children(11). The Pediatric Quality of Life 
Inventory (PedsQL) 4.0 stands out as a scale to measure 
quality of life of both healthy children and children with 
chronic diseases. This questionnaire has been recently trans-
lated and culturally validated for use in Brazilian children(12). 
The Medical Outcomes Study 36-Item Short-Form Health 
Survey (SF-36) is a general instrument to evaluate quality 
of life, easy to administer and to understand. 
This study used the SF-36 and the PedsQL questionnaires 
to measure HRQL of children and adolescents with SCD fol-
lowed up in a reference blood center and to compare findings 
with those of a control group of the same age.
Method
This study was approved by the Ethics in Research 
Committee of the Escola Paulista de Medicina of the 
Universidade Federal de São Paulo (EPM/Unifesp) and the 
Hemocentro de Alagoas (HEMOAL), in Brazil. Patients and 
controls and their caregivers (parents and guardians) received 
information about the study and signed an informed consent 
term in the presence of the author.
This cross-sectional study included a convenience sample 
and was conducted from March to December 2009. Of 495 
patients with SCD detected by hemoglobin electrophoresis 
who were registered in the blood center, only the children 
aged 5 to 18 years were included in the study. According 
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to the database, there were 162 patients in that age group 
registered in HEMOAL. Patients and their caregivers were 
invited by the author to come to HEMOAL where meetings 
to explain the study were conducted and where they were 
asked to sign the informed consent term. Exclusion criteria 
were: physical comorbidities (stroke, femoral head avascular 
necrosis and lung disease) or mental diseases (cognitive de-
velopment delay and psychic disorders) and absence caregiver 
during consultation. Exclusion criteria for patient parents 
were chronic or acute disease in the previous 30 days. A total 
of 100 patients were included in the study. 
The control group had 50 healthy children and adoles-
cents that studied in a public school in a suburb of Maceió, 
Brazil, whose socioeconomic status was the same as that of 
the patients. They were also subdivided into the same age 
groups, together with their parents or guardians. 
Quality of life was measured using the SF-36 and the 
PedsQL 4.0 questionnaires in three stages.
Stage 1
The general PedsQL 4.0(13) questionnaire translated to 
Portuguese and adapted to the Brazilian culture was applied 
to the patients. This questionnaire has versions for four 
age groups: 2–4, 5–7, 8–12 and 13–18 years. Its domains 
evaluate problems such as physical capacity, emotional and 
social aspects and school activities. Items are score-reversed 
and linearly transformed using a 0 to 100 scale (0=100, 
1=75, 2=50 and 4=0), so that higher scores represent bet-
ter quality of life(13). In the administration of PedsQL 4.0, 
children were asked how much of each problem they had 
experienced in the previous month. In the reports of children 
aged 5 to 18 years and their parents, a five point scale was 
used (0=never; 1=almost never; 2=sometimes; 3=often; 
and 4=almost always). For children aged 5 to 7 years, the 
scale was simplified to three points (1=never; 2=sometimes; 
3=many times, and each answer was given according to a 
visual analog scale with a happy, a neutral and a sad face.
Stage 2
The general SF-36 questionnaire translated to Portuguese 
and adapted to the Brazilian culture(14) was applied to evalu-
ate the impact of the disease on the patients’ parents. SF-36 
is a multidimensional questionnaire with 36 items divided 
into 8 scales or domains: functional capacity, physical aspects, 
pain, general health, vitality, social and emotional aspects and 
mental health. The final score ranges from 0 to 100, where 0 
corresponds to the worst general health and 100, the best(14). 
The present instrument version has eight domains grouped 
into two components: physical and mental. Each item is evalu-
ated by the sum of points (Likert-like scale), and values range 
from 0 to 100 points. The highest scores correspond to better 
quality of life. Scores are calculated according to the points of 
the items in each domain, as well as those of the components 
that are derivations of the related domains.
Stage 3
The questionnaires were applied to the control group of 50 
children and adolescents (5 to 18 years) and their caregivers 
after the school board granted permission.
For statistic analyses, the Kolmogorov-Smirnov test was 
used, and results showed that the domain scores were not 
normally distributed. Therefore, the nonparametric Mann-
Whitney test was used to compare domain values. All 
analyses were conducted using the Statistical Package for 
the Social Sciences (SPSS) 13.0.
Results 
The group of patients had 64 girls and 36 boys, and 18 
were aged 5 to 7 years, 32, 8 to 12 years; and 50, 13 to 18 
years. The control group had 31 girls and 19 boys, and 11 were 
aged 5 to 7 years; 19, 8 to 12 years; and 20, 13 to 18 years.
PedsQL 4.0 scores for the patients and controls are shown 
in Table 1. Patient scores in all aspects were significantly 
lower than those of controls (p<0.0001). 
HRQL results for the parents are shown in Table 2. 
Parents’ scores, in all aspects, were significantly lower than 
those of the control participants (p<0.0001). 
Discussion
This study found that SCD is associated with limitations 
in different aspects of HRQL, particularly physical, social, 
emotional and school aspects. In all those aspects, PedsQL 
4.0 scores were lower than those found for normal children 
and adolescents of the same age. 
This negative impact, particularly in the physical aspect, is 
associated with pain due to SCD and the overload of work due 
to the care and attention directed to the child or adolescent 
with the disease(15). Pain is the complication that has the great-
est impact on HRQL of patients with SCD and their families, 
although its intensity is variable and depends on individual 
characteristics, family and cultural context and the multi-
professional team that is responsible for their health care(6,16).
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healthcare workers should have a global understanding of 
patients and caregivers to promote strategies that have a 
higher possibility of improving well-being and health(17,18).
A chronic disease in childhood generates the need of 
greater parental participation in the care provided to the 
child and adaptation to new situations along time(19). Even 
The negative repercussion in the mental components 
and domain may be a result of the excessive concerns that 
caregivers have with the patient’s health, of the difficulty 
in dealing with the disease symptoms and of the possible 
changes in the family routine because of medical treatments 
and frequent hospitalizations. These findings indicate that 
Table 1 - Score of the Pediatric Quality of Life Inventory (PedsQL) 4.0 for the three age groups of children and adolescents with 
sickle cell and healthy controls
Group of patients Control group
p-value
Mean Standard Deviation Mean
Standard 
Deviatio
5–7 years n= 18 n=11
Physical 56.16 12.33 91.81 9.36 <0.0001
Emotional 70.55 13.04 96.36 9.24 <0.0001
Social 79.44 12.11 98.18 6.03 <0.0001
School 68.88 11.82 93.63 12.06 <0.0001
8–12 years n= 32 n=19
Physical 48.37 13.77 94.10 6.64 <0.0001
Emotional 75.31 12.11 92.89 7.69 <0.0001
Social 72.65 9.50 95.00 7.07 <0.0001
School 65.15 15.78 97.10 6.08 <0.0001
13–18 years n= 50 n=20
Physical 42.86 13.77 94.55 6.31 <0.0001
Emotional 71.50 13.41 96.00 6.40 <0.0001
Social 72.10 11.56 95.50 8.09 <0.0001
School 57.60 17.61 94.50 9.30 <0.0001
Table 2 - Score of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) for caregivers of patients with sickle 
cell disease and for controls
Domain
Group of patients Control group
p-value
Minimum Maximum Mean Standard deviation Minimum Maximum Mean
Standard 
deviation
Functional capacity 15.0 100.0 54.6 17.2 75.0 100.0 92.6 9.3 <0.0001
Limitations due to 
physical aspects 0.0 100.0 66.8 41.6 100.0 100.0 100.0 0.0 <0.0001
Pain 0.0 70.0 32.5 16.1 50.0 70.0 51.6 5.5 <0.0001
General health 10.0 95.0 62.4 20.7 90.0 100.0 96.5 4.2 <0.0001
Vitality 10.0 85.0 56.2 16.2 70.0 75.0 72.2 2.5 <0.0001
Social aspects 12.0 100.0 77.5 15.6 87.5 100.0 99.0 3.4 <0.0001
Limitations due to 
emotional aspects 0.0 100.0 74.9 36.6 100.0 100.0 100.0 0.0 <0.0001
Mental health 40.0 96.0 69.5 17.9 96.0 100.0 97.9 2.0 <0.0001
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healthy individuals experience changes in their expectations 
and in the feeling of well-being along life, and adolescents are 
less happy with their family relationships than children(20).
Palermo et al(21) reported a greater commitment with 
physical health among adolescents with SCD  than among 
children when they evaluated HRQL of children and adoles-
cents according to their parent. However, Panepinto et al(22) 
did not find any significant differences in HRQL when 
comparing the scores of children and adolescents with SCD, 
neither in the physical nor in the psychosocial domains.
According to Silver et al(23) and Sloper(24), a chronic dis-
ease in childhood involves the risk of psychological and 
psychosocial problems for parents and family members 
along the years. In a study conducted by Moskowitz et  al(25), 
the mothers of children with SCD had a higher risk of de-
pression than the mothers of healthy children. Caregivers 
of patients with SCD usually experience feelings of guilt, 
anxiety and depression associated with the hereditary aspect 
of the disease, the medical follow-up and the social and 
financial demands posed by a chronic disease. Therefore, the 
caregiver’s well being may be compromised, particularly 
the mental construct. These results support the need to 
give greater attention and promote more intensively the 
mental health of these individuals(17,18,26). Socioeconomic 
factors affect the quality of life of patients(27) with sickle 
cell disease, as already described in the study conducted 
by Felix et al(28) in Uberaba, Brazil.
The socioeconomic condition is relatedrelated to quality 
of life, which might have affected the results of this study. 
However, the control group had the same socioeconomic 
conditions, which minimized its impact.
In the group of patients with SCD, the survey was 
not conducted with all patients that were followed up 
in HEMOAL due to logistic limitations. Moreover, the 
exclusion of patients that did not come to the consultation 
may have affected results, because those patients may have 
missed because they were hospitalized or were fine and 
decided not to come to the consultation, or, still, because 
they were lost to follow-up. The number of painful crises 
and transfusions in the previous 12 months in children and 
adolescents, factors that are directly associated with qual-
ity of life, were not included in the analysis because that 
information was not provided by the patients’ parents or 
family member and was not available in the patients charts, 
as they were not dealt with in HEMOAL. Children and 
adolescents with SCD are individuals exposed to several 
factors that may determine a reduction in the physical or 
psychosocial domains of quality of life. Educational ef-
forts directed to healthcare workers and family members 
of patients with SCD should be increased to identify the 
problems associated with their health. Therefore, instru-
ments that can detect some type of risk, such as the PedsQL 
4.0, are essential for healthcare workers involved in the 
treatment of this population. They provide the necessary 
instruments to interfere precisely in one or more aspects.
The act of taking care demands an overload of attention 
and intense dedication and, as the family is the main actor 
in this role, the healthcare team has to ensure that parents 
have the conditions to reorganize their lives physically and 
emotionally in face of this new phase of responsibility, be-
cause caregivers are the healthcare workers’ best allies in the 
treatment of their patients’ health.
Our findings confirmed the need to conduct a more de-
tailed analysis of HRQL of patients with sickle cell anemia. 
The results of this study showed significant differences 
between the groups under study, which reinforced the need 
to promote prevention programs and organize multiprofes-
sional teams. 
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